Edith Oláh

16.8k total citations
78 papers, 2.1k citations indexed

About

Edith Oláh is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Edith Oláh has authored 78 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 27 papers in Genetics and 21 papers in Oncology. Recurrent topics in Edith Oláh's work include Biochemical and Molecular Research (21 papers), BRCA gene mutations in cancer (20 papers) and Genetic factors in colorectal cancer (13 papers). Edith Oláh is often cited by papers focused on Biochemical and Molecular Research (21 papers), BRCA gene mutations in cancer (20 papers) and Genetic factors in colorectal cancer (13 papers). Edith Oláh collaborates with scholars based in Hungary, United States and United Kingdom. Edith Oláh's co-authors include George Weber, Béla Csókay, J. Papp, Noémi Prajda, May S. Lui, Yutaka Natsumeda, Tamás I. Orbán, Diana Y. Tzeng, N Prajda and Zoltán Szentirmay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Edith Oláh

77 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edith Oláh Hungary 26 1.2k 546 408 321 307 78 2.1k
Rifat Pamukcu United States 28 1.5k 1.3× 986 1.8× 681 1.7× 252 0.8× 498 1.6× 50 3.5k
Willi Kreis United States 27 1.1k 0.9× 176 0.3× 722 1.8× 97 0.3× 271 0.9× 87 2.4k
Alan J. Townsend United States 33 1.9k 1.6× 207 0.4× 756 1.9× 157 0.5× 322 1.0× 60 2.7k
Joell J. Gills United States 28 2.0k 1.7× 108 0.2× 1.1k 2.6× 254 0.8× 452 1.5× 47 3.2k
Xiaohe Yang United States 25 1.8k 1.6× 229 0.4× 818 2.0× 192 0.6× 396 1.3× 51 2.7k
Su-Ryang Kim Japan 19 1.6k 1.4× 550 1.0× 448 1.1× 125 0.4× 491 1.6× 27 2.2k
T Sugimura Japan 24 1.7k 1.4× 329 0.6× 691 1.7× 272 0.8× 879 2.9× 64 3.7k
Erkan Baloglu United States 30 1.9k 1.6× 121 0.2× 1.2k 2.9× 185 0.6× 234 0.8× 85 3.0k
Alexander A. Chumanevich United States 24 989 0.9× 164 0.3× 419 1.0× 124 0.4× 236 0.8× 46 1.8k
George G. Chen Hong Kong 31 2.2k 1.9× 255 0.5× 862 2.1× 282 0.9× 1.1k 3.6× 119 3.6k

Countries citing papers authored by Edith Oláh

Since Specialization
Citations

This map shows the geographic impact of Edith Oláh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Oláh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Oláh more than expected).

Fields of papers citing papers by Edith Oláh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith Oláh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Oláh. The network helps show where Edith Oláh may publish in the future.

Co-authorship network of co-authors of Edith Oláh

This figure shows the co-authorship network connecting the top 25 collaborators of Edith Oláh. A scholar is included among the top collaborators of Edith Oláh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edith Oláh. Edith Oláh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bozsik, Anikó, Tímea Pócza, Erika Tóth, et al.. (2025). Whole genome sequencing completes the molecular genetic testing workflow of patients with Lynch syndrome. npj Genomic Medicine. 10(1). 5–5. 1 indexed citations
2.
Papp, J., Vince Kornél Grolmusz, Anikó Bozsik, et al.. (2024). Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. International Journal of Molecular Sciences. 25(23). 12546–12546. 3 indexed citations
3.
Butz, Henriett, J. Papp, Anikó Bozsik, et al.. (2023). PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer. Cancers. 15(17). 4350–4350. 3 indexed citations
4.
Bozsik, Anikó, J. Papp, Vince Kornél Grolmusz, et al.. (2022). Reclassification of Five BRCA1/2 Variants with Unknown Significance Using Complex Functional Study. Cancer Research and Treatment. 54(4). 970–984. 2 indexed citations
5.
Butz, Henriett, J. Papp, Anikó Bozsik, et al.. (2021). Application of Multilayer Evidence for Annotation of C-Terminal BRCA2 Variants. Cancers. 13(4). 881–881. 4 indexed citations
6.
Polgár, Csaba, Edith Oláh, Gábor Rubovszky, et al.. (2019). A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36–45 years) breast cancer patients. European Journal of Surgical Oncology. 45(11). 2009–2015. 9 indexed citations
7.
Singer, Christian F., Judith Balmañà, Nicole Bürki, et al.. (2018). Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations. European Journal of Cancer. 106. 54–60. 25 indexed citations
8.
Papp, J., et al.. (2009). Deletions removing the last exon ofTACSTD1constitute a distinct class of mutations predisposing to Lynch syndrome. Human Mutation. 30(2). 197–203. 117 indexed citations
9.
Weber, George, et al.. (2003). Targeting signal transduction. Advances in Enzyme Regulation. 43(1). 47–56. 20 indexed citations
10.
Bocsi, József, Erzsébet Rásó, Tamás I. Orbán, et al.. (2001). Constitutive intracellular expression and activation-induced cell surface up-regulation of CD44v3 in human T lymphocytes. European Journal of Immunology. 31(2). 600–608. 20 indexed citations
11.
Morrison, Patrick J., C. M. Steel, N. C. Nevin, et al.. (2000). Insurance considerations for individuals with a high risk of breast cancer in Europe:Some recommendations. Research Explorer (The University of Manchester). 3 indexed citations
12.
Brożek, Izabela, et al.. (2000). Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. Human Mutation. 15(5). 480–481. 27 indexed citations
13.
Szabo, Csilla I., I Besznyák, Béla Csókay, et al.. (2000). Prevalence of founderBRCA1 andBRCA2 mutations among breast and ovarian cancer patients in hungary. International Journal of Cancer. 86(5). 737–740. 85 indexed citations
14.
Pápai, Zsuzsa, et al.. (1997). P53 overexpression as an indicator of overall survival and response to treatment in osteosarcomas. Pathology & Oncology Research. 3(1). 15–19. 18 indexed citations
15.
Weber, George, Fei Shen, Noémi Prajda, et al.. (1997). Regulation of the signal transduction program by drugs. Advances in Enzyme Regulation. 37. 35–55. 36 indexed citations
16.
Papp, J., et al.. (1996). Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas. British Journal of Cancer. 74(10). 1592–1597. 23 indexed citations
17.
Singhal, Radhey L., et al.. (1995). Quercetin Down-Regulates Signal Transduction in Human Breast Carcinoma Cells. Biochemical and Biophysical Research Communications. 208(1). 425–431. 104 indexed citations
18.
Weber, George H., Minako Nagai, N Prajda, et al.. (1991). AZT: A Biochemical Response Modifier of Methotrexate and 5-Fluorouracil Cytotoxicity in Human Ovarian and Pancreatic Carcinoma Cells. PubMed. 3(4). 127–132. 25 indexed citations
19.
Oláh, Edith, et al.. (1987). Characterization of "fetal-type" acetylcholinesterase in hemin-treated K562 cell culture.. PubMed. 12(3). 647–55. 14 indexed citations
20.
Oláh, Edith, et al.. (1970). Effect of maleic hydrazide on flower formation in egg-plants (Solanum melongena L.).. Acta Agronomica Hungarica. 19. 33–36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rifat Pamukcu Breakdown of academic impact, for papers by Willi Kreis Breakdown of academic impact, for papers by Alan J. Townsend Breakdown of academic impact, for papers by Joell J. Gills Breakdown of academic impact, for papers by Xiaohe Yang Breakdown of academic impact, for papers by Su-Ryang Kim Breakdown of academic impact, for papers by T Sugimura Breakdown of academic impact, for papers by Erkan Baloglu Breakdown of academic impact, for papers by Alexander A. Chumanevich Breakdown of academic impact, for papers by George G. Chen
Rankless by CCL
2026